Search Results
Feb 23, 2026, 09:15 ET Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Feb 23, 2026, 09:01 ET Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics' best-in-class NGS sample preparation chemistry with Volta's digital fluidics automation
More news about: Volta Labs Inc.
Feb 23, 2026, 09:01 ET Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics' best-in-class NGS sample preparation chemistry with Volta's digital fluidics automation
More news about: Volta Labs Inc.
Feb 23, 2026, 09:00 ET Complete Genomics Enters Definitive Agreement to Be Acquired by Swiss Rockets AG
software development team.About Complete GenomicsComplete Genomics is a U.S.-based life sciences company providing end-to-end DNA sequencing platforms, reagents, and software for research applications. Since its founding in 2005, the company has been at the forefront of high-throughput,
More news about: Complete Genomics
Feb 23, 2026, 09:00 ET FROM THE GROUND UP: BIRKENSTOCK EMPHASIZES ITS EXPERTISE IN CLOSED SHOES WITH THE LAUNCH OF THE HIGHWOOD MOC LACE LOW
supported by a campaign conceptually aligning with BIRKENSTOCK's promise of empowering everyone to walk as nature intended, deeply rooted in the brand DNA. The distinctive and unique technology of the original BIRKENSTOCK footbed, patented a century ago, has made the brand globally renowned and
More news about: BIRKENSTOCK Group
Feb 23, 2026, 09:00 ET „FROM THE GROUND UP": BIRKENSTOCK UNTERSTREICHT KOMPETENZ IN GESCHLOSSENEN SCHUHEN MIT DEM LAUNCH DES HIGHWOOD MOC LACE LOW
unter der Headline „From the Ground Up" unterstützt, die konzeptionell auf den Purpose vom "Naturgewollten Gehen" einzahlt, das tief in der BIRKENSTOCK DNA verwurzelt ist. Die einzigartige, charakteristische Technologie des original BIRKENSTOCK Fußbetts, vor einem Jahrhundert patentiert, hat die Marke weltweit
More news about: BIRKENSTOCK Group
Feb 23, 2026, 09:00 ET FROM THE GROUND UP: BIRKENSTOCK EMPHASIZES ITS EXPERTISE IN CLOSED SHOES WITH THE LAUNCH OF THE HIGHWOOD MOC LACE LOW
supported by a campaign conceptually aligning with BIRKENSTOCK's promise of empowering everyone to walk as nature intended, deeply rooted in the brand DNA. The distinctive and unique technology of the original BIRKENSTOCK footbed, patented a century ago, has made the brand globally renowned and sets
More news about: BIRKENSTOCK Group
Feb 23, 2026, 08:00 ET RevSpring Announces Grounding Layer to Help Healthcare Organizations Improve Care Access and Control AI Cost
designed to deliver fast grounding responses that avoid "agent lag.""Clinically rigorous, relevant care guidance has been in the Kyruus solution DNA since the beginning," said Morgan Beschle, Vice President of Kyruus Product at RevSpring. "We are well-positioned to solve the grounding problem because
More news about: RevSpring
Feb 23, 2026, 07:15 ET ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload. The potent payload binds to DNA minor groove with little distortion, remaining less visible to DNA repair mechanisms. This ultimately results in cell cycle arrest and tumor cell death.The U.S. Food and Drug
More news about: ADC Therapeutics SA
Feb 23, 2026, 05:27 ET Vantage Towers Spain partners with Elisa Industriq's Gridle to enable virtual power plant capabilities across mobile sites
was originally developed to optimize Elisa's own extensive fleet of batteries across Finland and Estonia. Today, leading telecom companies, including DNA Towers Finland (part of Telenor Group), use the service to optimize charging, reduce emissions and participate more efficiently in energy markets. Gridle
More news about: Elisa Oyj
Feb 20, 2026, 10:00 ET New England Biolabs® to present latest updates in Next Generation Sequencing Sample Preparation at 2026 AGBT Meeting
Monarch® Mag Cell-free DNA (cfDNA) Extraction Kit, to enable scalable, reproducible cfDNA isolation from biofluids.
More news about: New England Biolabs, Inc.
Feb 20, 2026, 08:00 ET Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
clinical benefit in a confirmatory trial(s). NRG1 gene fusions and other gene fusions are best detected using the combination of tissue-based DNA and RNA next-generation sequencing.For more information on the eNRGy trial and zenocutuzumab-zbco, please visit
More news about: Partner Therapeutics, Inc.
Feb 20, 2026, 03:00 ET Clarins unveils the AI Shade Finder, the most precise ever foundation matcher
Clarins boutiques and counters, the AI Shade Finder has been designed as a seamless, intuitive and reassuring in-store service. True to Clarins DNA, the project is the result of a global co-creation journey involving Clarins' Innovation Lab, Clarins make-up artists and Beauty Advisors, IlluminateAI
More news about: Groupe Clarins
Feb 20, 2026, 03:00 ET Clarins unveils the AI Shade Finder, the most precise ever foundation matcher
Clarins boutiques and counters, the AI Shade Finder has been designed as a seamless, intuitive and reassuring in-store service. True to Clarins DNA, the project is the result of a global co-creation journey involving Clarins' Innovation Lab, Clarins make-up artists and Beauty Advisors, IlluminateAI
More news about: Groupe Clarins
Feb 19, 2026, 23:30 ET Building India's EdTech and AI Roadmap for Equitable Learning for Every Child
"Under the leadership of PM Modi, Digital India has truly come alive as a powerful means of empowerment. Rapid adoption of technology is part of India's DNA. Our commitment is clear — technology must connect to every aspect of life and be integrated into everyday living so that it delivers ease, opportunity,
More news about: Central Square Foundation (CSF)
Feb 19, 2026, 19:29 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papilloma virus ("HPV"). The Company's DNA medicines are comprised of two components: (i) DNA plasmids, which are small circular DNA molecules that purportedly work like
More news about: Pomerantz LLP
Feb 19, 2026, 14:25 ET iMused Marks First Official Platform Song Release With "The Bag," Written by CLEO-P Using Arya Starr's Musical DNA as the Muse Source
Musical DNA Technology™, which analyzes an artist's creative fingerprint across 12+ musical dimensions to support original, high-fidelity tracks, support faster songwriting and production, while preserving an ethical framework that includes attribution and royalties for Muse artists when their DNA is used
More news about: iMused
Feb 19, 2026, 12:46 ET Eagle Wireless Raises $30 Million Series B to Accelerate R&D Efforts alongside U.S.-Based Device Production
concentration, and real operational support. The firm invests in disruptive technology-driven companies in the Pre-seed through Series A stages. Asymmetric's DNA is different by design: its team blends rigorous investing experience with hands-on operating expertise, having built, scaled, and acquired companies
More news about: Eagle Wireless
Feb 19, 2026, 12:36 ET Rosalind Franklin University Innovation and Research Park Welcomes Clinical Research Organization's Phase I/II Clinical Site
embodies the spirit of inquiry and excellence modeled by its namesake, Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Feb 19, 2026, 10:56 ET Wireless Zone Named Among Top Franchises in Entrepreneur Magazine's Franchise 500®; Achieves Highest-Ever Ranking
Wireless Zone actively invests in local and national causes. Community giveback initiatives are a core part of Round Room and each of its entities' DNA as the company regularly organizes events that leave positive impacts on the communities it serves. On a larger, national scale, they host quarterly initiatives
More news about: Wireless Zone
Feb 19, 2026, 10:00 ET Introducing the MARVEL OREO Stuf of Doom Cookies: The Culmination of Marvel and the OREO Brand's Iconic Collaboration
EAST HANOVER, N.J., Feb. 19, 2026 /PRNewswire/ -- When the OREO brand fuses its playful DNA with Marvel's epic storytelling, you get more than a product launch, you get an unforgettable experience that cements the OREO brand as a snacking powerhouse
More news about: Mondelēz International
Feb 19, 2026, 08:15 ET MDA Space Launches 49North, a Canadian defence business delivering multi-domain and mission-critical capabilities
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Feb 19, 2026, 08:00 ET Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
2026BOSTON, Feb. 19, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year
More news about: Ginkgo Bioworks
Feb 19, 2026, 07:00 ET DynPro and Turgon AI Announce Strategic Partnership to Transform Enterprise IT Modernization with AI-Native Platform & Solutions
business value from the ecosystem of AI applications that their legacy systems couldn't support. Together, we are bringing Silicon Valley's innovation DNA and builder mindset into an industry DynPro understands deeply and at scale, jointly building toward a future where IT continuously evolves through AI-human
More news about: DynPro
Feb 19, 2026, 06:00 ET EPAM Reports Results for Fourth Quarter and Full Year 2025
invest in AI innovation, talent development and strategic partnerships, we are driving our own transformation, building on top of our core engineering DNA and strengthening our strategic positioning to win in the AI-Native Build era."Fourth Quarter 2025 HighlightsRevenues
More news about: EPAM Systems, Inc.